Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
280.08
-5.55 (-1.94%)
Feb 21, 2025, 4:00 PM EST - Market closed
Bio-Rad Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -1,844 | -637.3 | -3,628 | 4,254 | 3,814 | Upgrade
|
| Depreciation & Amortization | 151.6 | 145.9 | 137.3 | 137.6 | 175.7 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -2.5 | -1.4 | - | -11.7 | Upgrade
|
| Asset Writedown & Restructuring Costs | 29.5 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 2,657 | 1,252 | 5,206 | -4,925 | -4,491 | Upgrade
|
| Stock-Based Compensation | 62.3 | 61.3 | 60.9 | 51.2 | 41.6 | Upgrade
|
| Other Operating Activities | 20 | -12 | 22.1 | 8.74 | -32.53 | Upgrade
|
| Change in Accounts Receivable | 16.2 | 11.4 | -87.4 | -20.4 | -15 | Upgrade
|
| Change in Inventory | 8.5 | -46.3 | -158.8 | 46.1 | -52.1 | Upgrade
|
| Change in Accounts Payable | -40.9 | -51.8 | -94.2 | 69.9 | 124.7 | Upgrade
|
| Change in Income Taxes | 24.1 | -21.3 | -1.2 | -28.8 | 39 | Upgrade
|
| Change in Other Net Operating Assets | -1.9 | -2.2 | -26.8 | -8.6 | 10.9 | Upgrade
|
| Operating Cash Flow | 455.2 | 374.9 | 194.4 | 669.5 | 585 | Upgrade
|
| Operating Cash Flow Growth | 21.42% | 92.85% | -70.96% | 14.44% | 27.76% | Upgrade
|
| Capital Expenditures | -165.6 | -156.7 | -112.8 | -133.75 | -108.56 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.1 | 0.2 | 0.2 | 0.05 | 0.07 | Upgrade
|
| Cash Acquisitions | - | - | -100.7 | -125.52 | -96.66 | Upgrade
|
| Divestitures | - | 2.5 | 1.4 | - | 12.24 | Upgrade
|
| Sale (Purchase) of Intangibles | -23.4 | - | -1.5 | - | 3.41 | Upgrade
|
| Investment in Securities | 28.7 | 174.2 | -994.2 | -84.73 | 119.6 | Upgrade
|
| Investing Cash Flow | -160.2 | 20.2 | -1,208 | -797.38 | -69.89 | Upgrade
|
| Long-Term Debt Issued | - | - | 1,186 | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.4 | -0.5 | -0.5 | -3.02 | -426.94 | Upgrade
|
| Net Debt Issued (Repaid) | -0.4 | -0.5 | 1,186 | -3.02 | -426.94 | Upgrade
|
| Issuance of Common Stock | 19.2 | 18.5 | 17.6 | 20.63 | 20.2 | Upgrade
|
| Repurchase of Common Stock | -207 | -443.6 | -229.7 | -72.48 | -112.93 | Upgrade
|
| Other Financing Activities | -30.6 | - | - | -0.56 | -3.37 | Upgrade
|
| Financing Cash Flow | -218.8 | -425.6 | 973.6 | -55.43 | -523.04 | Upgrade
|
| Foreign Exchange Rate Adjustments | 9.2 | 0.4 | 3 | -12.64 | 12.43 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -0.04 | -0.03 | Upgrade
|
| Net Cash Flow | 85.4 | -30.1 | -36.6 | -195.98 | 4.46 | Upgrade
|
| Free Cash Flow | 289.6 | 218.2 | 81.6 | 535.75 | 476.44 | Upgrade
|
| Free Cash Flow Growth | 32.72% | 167.40% | -84.77% | 12.45% | 32.58% | Upgrade
|
| Free Cash Flow Margin | 11.28% | 8.17% | 2.91% | 18.33% | 18.72% | Upgrade
|
| Free Cash Flow Per Share | 10.26 | 7.47 | 2.74 | 17.74 | 15.80 | Upgrade
|
| Cash Income Tax Paid | 99.4 | 129.6 | 158.3 | 134.68 | 65.24 | Upgrade
|
| Levered Free Cash Flow | 180.86 | 106.85 | 2.86 | 485.98 | 427.88 | Upgrade
|
| Unlevered Free Cash Flow | 211.43 | 137.72 | 26.68 | 486.95 | 441.54 | Upgrade
|
| Change in Net Working Capital | -18.4 | 123.9 | 358.85 | -78.94 | -66.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.